X0306 4 2019-11-04 true 0001720725 Oyster Point Pharma, Inc. OYST 0001472698 KKR Fund Holdings L.P. C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true 0001081714 KRAVIS HENRY R C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true 0001081715 ROBERTS GEORGE R C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 2800 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025 true 0001472694 KKR Management LLC C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true 0001404912 KKR & Co. Inc. C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true 0001743754 KKR Group Holdings Corp. C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true 0001472697 KKR Fund Holdings GP Ltd C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019 true Common Stock, par value $0.001 per share 2019-11-04 4 C 0 884622 A 884622 I See footnotes Common Stock, par value $0.001 per share 2019-11-04 4 P 0 155000 16 A 1039622 I See footnotes Series B Convertible Preferred Stock 2019-11-04 4 C 0 884622 D Common Stock, par value $0.001 per share 884622 0 I See footnotes These shares of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock, on a one-for-one basis immediately prior to the completion of the Issuer's initial public offering. The securities reported herein are held by Falcon Vision LLC. KKR Health Care Strategic Growth Fund L.P., as the managing member of Falcon Vision LLC, KKR Associates HCSG L.P., as the general partner of KKR Health Care Strategic Growth Fund L.P., KKR HCSG GP LLC, as the general partner of KKR Associates HCSG L.P., KKR Fund Holdings L.P., as the sole member of KKR HCSG GP LLC, KKR Fund Holdings GP Limited, as a general partner of KKR Fund Holdings L.P., KKR Group Holdings Corp., as a general partner of KKR Fund Holdings L.P. and the sole shareholder of KKR Fund Holdings GP Limited, KKR & Co. Inc., as the sole shareholder of KKR Group Holdings Corp., KKR Management LLC, as the Class B common stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts, as the designated members of KKR Management LLC, may be deemed to be the beneficial owners having shared voting and investment power with respect to the shares described in this footnote. Each of Messrs. Kravis and Roberts disclaims beneficial ownership of the shares held by Falcon Vision LLC. Due to the limitations of the Securities and Exchange Commission's electronic filing system, Falcon Vision LLC, KKR Health Care Strategic Growth Fund L.P., KKR Associates HCSG L.P. and KKR HCSG GP LLC have filed a separate Form 4 relating to the securities reported herein. KKR FUND HOLDINGS L.P. By: KKR Fund Holdings GP Limited, its general partner By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Director 2019-11-04 HENRY R. KRAVIS By: /s/ Terence Gallagher, Attorney-in-fact 2019-11-04 GEORGE R. ROBERTS By: /s/ Terence Gallagher, Attorney-in-fact 2019-11-04 KKR MANAGEMENT LLC By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer 2019-11-04 KKR & CO. INC. By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer 2019-11-04 KKR GROUP HOLDINGS CORP. By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Chief Financial Officer 2019-11-04 KKR FUND HOLDINGS GP LIMITED By: /s/ Terence Gallagher, Attorney-in-fact for William J. Janetschek, Director 2019-11-04